Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amlodipine benazepril pharmaceutical composition

A technology of amlodipine and benazepril hydrochloride, applied in drug combinations, active ingredients of heterocyclic compounds, pharmaceutical formulations, etc., can solve the problems of enhanced hydrophobicity of tablets, large number of machines, and influence of water infiltration, etc., to achieve improved Dissolution and disintegration, simple preparation process, and the effect of improving dispersion uniformity

Active Publication Date: 2013-04-17
YANGTZE RIVER PHARM GRP GUANGZHOU HAIRUI PHARM CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] 1. The dissolution rate of amlodipine besylate in the prepared amlodipine benazepril tablets is low, which is not suitable for rapid onset of action of the drug and has a certain impact on clinical application
Thereby, need to adopt improved method to prepare amlodipine benazepril tablet, for example, can improve its stripping by micronization, in actual preparation, after hydrophobic material pulverizes, along with the reduction of particle size, surface free can increase, the particles are prone to re-agglomeration, so the actual benefit of crushing is not high; on the other hand, due to the small size of the hydrophobic material and the increase of the specific surface area, the hydrophobicity of the tablet will also be enhanced. On the contrary, it is not conducive to the dissolution of the tablet;
[0007] 2. The general preparation process uses magnesium stearate as a lubricant. Magnesium stearate is a hydrophobic substance. After excessive dosage or excessive stirring, it will cover the surface of the particles and affect the infiltration of water, resulting in amlodipine and benazepril tablets. Delayed disintegration (or dissolution) is not conducive to rapid therapeutic effect of the drug;
[0008] 3. The preparation of amlodipine and benazepril tablets by traditional wet granulation and tableting process: the process is complicated, and factors such as the amount of binder added, the drying time of granules, and the time of alcohol granulation and sieving have to be considered, and the number of machines required for production is large , The space is large, and because some factors need to rely on experience to judge, it may cause unstable product quality and large differences between batches, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amlodipine benazepril pharmaceutical composition
  • Amlodipine benazepril pharmaceutical composition
  • Amlodipine benazepril pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The amount of each raw material component prepared by the present embodiment for amlodipine benazepril tablet is:

[0034]

[0035] The concrete steps of present embodiment preparation amlodipine benazepril tablet are as follows:

[0036] a. Pulverize and sieve amlodipine besylate and benazepril hydrochloride, weigh amlodipine besylate, benazepril hydrochloride, micropowder silica gel, lactose, microcrystalline cellulose and hydroxymethyl Sodium starch;

[0037] b. In the weighed lactose, take 20% of the lactose and amlodipine besylate and mix them evenly in a high-efficiency mixer. The speed of the high-efficiency mixer is 12r / min, mix for 5min, and take a sample to detect the uniformity of the content , the content uniformity reaches the standard, and the mixture I is obtained after the mixing is completed;

[0038] c. Add the remaining lactose and benazepril hydrochloride to the mixture I in turn, mix well, the speed of the high-efficiency mixer is 12r / min, mix ...

Embodiment 2

[0043] The amount of each raw material component prepared by the present embodiment for amlodipine benazepril tablet is:

[0044]

[0045] The specific steps for preparing amlodipine and benazepril tablets in this embodiment are the same as in embodiment 1.

Embodiment 3

[0047] The amount of each raw material component prepared by the present embodiment for amlodipine benazepril tablet is:

[0048]

[0049] The specific steps for preparing amlodipine and benazepril tablets in this embodiment are the same as in embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an amlodipine and benazepril composition which is a tablet. The amlodipine benazepril tablet is obtained by treating amlodipine besylate and benazepril hydrochloride as active components, aerosil as a lubricant, lactose and microcrystalline cellulose as fillers and sodium carboxymethyl starch as a disintegrant and adopting a direct powder tabletting technology. The method has the advantages of simple process, and energy and time saving; and the prepared tablet has the advantages of stable quality, high dissolvability, and good disintegration.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical composition of amlodipine and benazepril, and the pharmaceutical composition is a tablet. Background technique [0002] Hypertension is a major risk factor for death from cardiovascular disease, and its prevalence accounts for 10% to 30% of adults. The effective rate of treating hypertension with a single drug is only 40%, although increasing the dosage can improve the efficacy , but it also increases the incidence of adverse reactions. In order to improve the efficacy, reduce the incidence of cardiovascular events, and reduce target organ damage, angiotensin-converting enzyme inhibitors and calcium antagonists are usually used in combination to treat hypertension, which is safe and effective , is well tolerated. [0003] Amlodipine besylate (amlodipine besylate) is the second generation of long-acting dihydropyridine calcium antagonists, which can relax coro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/55A61K31/4422A61K9/20A61K47/36A61K47/04A61P9/12
Inventor 彭旺
Owner YANGTZE RIVER PHARM GRP GUANGZHOU HAIRUI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products